Skip to main content
. 2002 Jun;68(6):2781–2793. doi: 10.1128/AEM.68.6.2781-2793.2002

TABLE 2.

Synthetic oligonucleotides used in this study

                                Oligonucleotide Sequencea
Oligonucleotides used for omcA experiments
    A5 5′-TTGATATCGGTGGCAGTGATGGRAAAGAT-3′
    A6 5′-TCAGTCGACTTAGTTACCGTGTGCTTCCAT-3′
Oligonucleotides used for omcB experiments
    B1 5′-CATGTCGCCTTTAGTCACTTA-3′
    B2 5′-AACCAGTTTGCCAGCATCATT-3′
    B5 5′-GCAGTGGTAATAACGGCAATGAT-3′
    B6 5′-TCAACAACTGCACCGAAAGACTC-3′
Oligonucleotides used for mtrA-mtrB experiments
    M1 5′-TACTGCCGGCACTTACCATCACA-3′
    M2 5′-GTGCGGTGTAGTCATGGCTGTTA-3′
Oligonucleotides used for altA experiments
    C1 5′-TGGTCGACTTGGCTTTCTAGTGGGCTCAACC-3′
    C2 5′-TGGTCGACCCCGCTTGGCTGATGGAATACAC-3′
    C3 5′-CTGATCGATCGGCATTGACAAGAATAAT-3′
    C4 5′-CTGATCGATTCAGGCCAGAGTGAGACT-3′
Oligonucleotides based on cat gene
    R1 5′-CAGACGGCATGATGAACCTGAATC-3′
    R2 5′-CCACCGTTGATATATCCCAATGGC-3′
Oligonucleotide based on Kmr gene
    K1 5′-ATTGCGATCGATTTATGCTTGTAAACCGTT-3′
a

Underlined regions indicate the following restriction endonuclease sites engineered into the oligonulceotides: ClaI sites in C3, C4, and K1; SalI sites in C1, C2, and A6; and an EcoRV site in A5.